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ABSTRACT 
There are strong correlations between ultrafine particle deposition in the 
lung and chronic respiratory illness. The growing prevalence of engineered 
nanoparticles (ENPs) in society presents a new lung toxicant exposure that has 
the potential to cause adverse affects in the lung, and specifically, on lung innate 
immune function. We examined the cytotoxicity of hafnium oxide (HfO2), cerium 
oxide (CeO2), and silicon oxide (SiO2) ENPs, and their micron-sized equivalents, 
to cultured human airway epithelial cells (16HBE14o-) in terms of cell death and 
reduction in paracrine ATP signaling as a measure of one aspect of innate 
immune function in lung epithelium. We used high-throughput real time cell 
analysis (RTCA) assays and fluorescent-based Live/Dead assays to evaluate cell 
death to establish cytotoxic levels of ENPs to airway epithelium. We used RTCA 
with digital imaging video microscopy to evaluate changes in ATP-induced cell 
signaling following exposure to low, non-cytotoxic doses of ENPs (10 - 50 mg/L). 
ENP induced cytotoxicity occurred only at high exposures, whereas acute (24 hr) 
incubations with ENPs resulted in altered ATP-induced cellular signaling at low 
doses of ENPs. We conclude that sub-cytotoxic exposures to ENPs can alter a 
basic innate immune function in lung epithelial cells that could contribute to 
respiratory disease. Such measurements of toxicity may be better indicators of 
potential health hazards of ENPs than simple cell death assays. 
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CHAPTER 1 - BACKGROUND AND LITERATURE REVIEW 
1.1 Introduction 
Engineered nanoparticles (ENPs) are intentionally produced structures with 
diameters less than 100 nm that confer physicochemical properties that differ 
from their bulk counterparts (Auffan et al., 2009; Gwinn, 2006). They can be 
composed of pure metals, metal oxides and sulfides, alloys, or various 
compounds (Karakoti et al., 2011 ), but their unique physicochemical properties 
are a function of their small size, chemical composition, surface structure, 
solubility, shape, and aggregation (Nel et al., 2006). Nanotechnology that 
incorporates the use of ENPs is transforming established fields such as medical 
diagnostics, energy conversion, and microelectronics. These fields are rapidly 
expanding and introducing new applications within areas of molecular 
electronics, drug design and delivery, and imaging and diagnostic systems. 
Nanoparticles are increasingly being used for commercial and industrial 
purposes including semiconductors, fillers, catalysts, biosensors, and cosmetics. 
Although these applications are being exploited for new nanotechnologies and 
potential human health benefits, they raise concerns for human health risks due 
to their possible negative effects on biological systems, acting at the cellular, 
subcellular, and protein levels. 
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1.2 Engineered Nanoparticles (ENPs) 
The use of nanotechnology in the field of medicine introduces many 
applications of ENPs. They are used as probes in imaging and diagnosis and 
can be linked to peptides, antibodies, or nucleic acids to detect products of 
cellular reactions (Gwinn, 2006). Nanoparticles that act as drug carrying vehicles 
to target specific sites are improving drug delivery systems. Although this 
advancing field of nanomedicine has many potential benefits, these applications 
directly and purposely expose humans to ENPs, which may carry negative health 
effects as well. Such risks have largely gone without appropriate evaluation. 
Exposure to ENPs is widespread other industries as well, where ENPs are 
used in the production of commercial goods and advanced electronics. ENPs 
are increasingly used for fillers, opacifiers, catalysts, semiconductors, cosmetics, 
pigments, fuel additives, polishing agents, UV absorbers, self-cleaning surface 
coatings, stain-resistant textiles, and microelectronics (Nel et al., 2006; 
Oberdorster et al., 2005; Xia et al., 2008). They are used in optical sensors 
based on metal nanoparticle arrays and single nanoparticles with properties that 
scatter light with remarkable efficiency (plasmonic) to detect molecular binding 
events and changes in molecular conformation (Anker et al., 2008). Gas and 
humidity sensors also utilize metal nanoparticle thin films, due to their ability to 
act as reactive sites to target specific gas molecules (Beliatis et al., 2011 ). 
Semiconductor manufacturing incorporates dispersions of nanoparticles as high 
12 
refractive index fluids in immersion lithography (Bremer et al., 2009). Colloidal 
lithography with silver nanoparticles has been used to fabricate nanostructure 
arrays for optics and optoelectronic purposes, such as for photovoltaic cells, 
light-emitting devices, and photo-detectors (Park et al., 2010). These uses of 
ENPs, and many more to follow, increase risk for unintentional exposure. 
1.2.1 Types of ENPs 
ENP materials used in a wide range of industry and research field are all 
associated with different physical, chemical, and toxicological properties. ENPs 
defined by their core composition can be grouped as either organic or inorganic 
(Ju-Nam and Lead, 2008; Peralta-Videa et al., 2011 ). Organic, or carbon-based, 
ENPs include fullerenes (Cso and C10) and carbon nanotubes. Inorganic ENPs 
include those based on metal oxides, metals, semiconductors, or quantum dots. 
Inorganic ENPs are becoming more prevalent in biomedical applications. In 
addition to carrying an active drug, they can act as diagnostic agents for 
spectroscopy or imaging (e.g. by using fluorescent tags or magnetic contrast 
agents). For successful therapeutic and drug delivery application, it is necessary 
to protect the surface of the ENP from agglomeration and clearing from the body. 
Surface modifications of the ENPs, such as the addition functional groups, can 
alter surface charge, biocompatibility, and solubility of the ENP. One promising 
functional group is the polymer Poly(ethylene glycol), which when attached to or 
coated on the ENP surface (i.e. PEGylation), has been found to be effective in 
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shielding the surface charge of ENPs and can improve the biomedical properties 
for use in a biological environment (Karakoti et al., 2011 ). 
Metal oxide ENPs are used in biological sciences, as well as in food, 
material, and chemical applications. Metal oxide ENPs like Ti02, Fe203, and 
ZnO are used in cosmetics and sunscreens. Si02 has been used in dental 
fillings and Ce02 is used in fuel additives (Ju-Nam and Lead, 2008). Hf02, with 
its high dielectric constant, is a promising material for replacing Si02 as the gate 
insulator in complementary metal-oxide semiconductor technology (Ceresoli, 
2006). Hf02 nanoparticles are also applied in immersion lithography to create 
high refractive index fluids, with can extend the resolution of conventional 
lithography for transfer of patterns to thin films in deep submicron range (Bremer 
et al., 2009). During the production processes of these ENP applications, 
particles are released into the process fluids and potentially work space. 
Consequently, occupational exposure and ENP emissions may result through the 
waste streams into the surrounding environment. 
1.3 Exposure Routes of Engineered Nanoparticles 
Human exposure to ENPs can occur in both occupational (e.g. 
manufacturing of nanomaterials) and medicinal (e.g. administered as 
pharmaceuticals) settings. Furthermore, as more ENPs are produced, their 
increased persistence in the environment will allow for re-entry into biological 




and retention, cellular and protein interactions, and potential adverse effects can 
be influenced by the physicochemical characteristics of the surface and core of 
the ENP (Nel et al., 2009; Oberdorster et al., 2005). 
Because of the size of nanoparticles, they are easily dispersed into the air 
in their native form in or in complex aerosols, making the lungs a potential target 
for airborne ENPs, possibly settling on the airway or alveolar epithelium. 
Particles that translocate over the alveolar epithelium may reach the interstitium 
or even enter the vascular circulation via the capillary endothelium (Muhlfeld et 
al., 2008). Another potential route of entry for ENPs is the skin, the largest organ 
of the body. Here, ENPs may become lodged within the avascular epidermis 
where they are protected from removal by phagocytosis (Oberdorster et al., 
2005). Although it is not addressed in these studies, the gastrointestinal tract is 
another portal of entry for ENP exposure, via oral ingestion. ENPs may be 
translocated through the mucosal lining and epithelial barrier of the intestine and 
enter the circulatory system within only one hour (Muhlfeld et al., 2008). 
1.3.1 Risks and Concerns of Engineered Nanoparticles 
Despite the many benefits and technological advances that have resulted 
from use of ENPs, there are potential health and environmental risks that should 
be considered. Similar to particulate matter originating from combustion-
generated ultrafine particles, ENPs that are intentionally manufactured can cause 
human toxicity effects and negatively impact the environment. 
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Concern over air pollution in the United States in the 1980s led to many 
studies on particulate matter originating from smoke, fumes, soot, and 
combustion by-products, mostly coming from exhaust stacks and tailpipes, but 
also secondary particles produced from condensation of vaporized materials or 
oxidation of atmospheric gases. These studies found that the smaller "inhalable 
particles" were of greatest concern, and thus were focused on particulate matter 
< 10 µm in aerodynamic diameter (PM10), or < 2.5 µm in diameter (PM2.s). 
Increased mortality and morbidity (both cardiovascular and respiratory) has been 
associated with particulate air pollution, even at moderate concentrations 
(Dockery and Pope, 1994 ). Furthermore, exposure to PM10 has been linked to 
reductions in lung function development (Horak et al., 2002) and increased 
hospital admissions in patients with chronic obstructive pulmonary disease 
(COPD), as well as asthma (Samoli et al., 2011) and atherosclerosis (Grahame 
and Schlesinger, 2010). 
The mechanisms for the adverse health effects linked to PM10 exposure 
are not well understood. One hypothesis is that PM10 particles cause oxidant 
stress that results in inflammation and injury to the airway epithelium. This 
hypothesis has been tested by investigating the effects of intratracheal instillation 
of PM10 in rat lungs (Li et al., 1997). A measured influx of neutrophils in the 
alveolar space indicated a significant inflammatory response, and an increased 
epithelial permeability indicated injury to the airway epithelium. Furthermore, 
when ultrafine carbon black particles (ufCB), composed entirely of ~20 nm 
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diameter particles, were compared to the larger PM10 particles, the smaller ufCB 
was found to have an even greater inflammatory response compared to PM10. 
This result showed that smaller particles have the potential to cause greater 
effects than larger particles. 
While ENPs can be similar in size to the incidental nanoparticles produced 
from air pollution, they are different because ENPs have unique physical and 
chemical properties that relate to their product applications. These ENPs, which 
are smaller than 100 nm in at least one dimension, create another source for 
human exposure to nano-sized particles and may have similar toxicological 
potentials and biological behavior as the particulate matter of air pollution (Fadeel 
and Garcia-Bennett, 2010). Therefore, previous studies focused on the adverse 
health effects of air pollution are relevant starting points from which to study 
ENPs. With humans purposely exposed to a wide range of ENPs for medical 
purposes and unintentionally exposed in manufacturing and occupational 
environments, it is important to carefully assess the toxicology of emerging 
ENPs, as well as their interactions with biological systems. 
1.3.2 Lung structure and its effect on ENP exposure and deposition 
The lung can be divided into two functional compartments: the conducting 
zone made up of airways (trachea, bronchi, and bronchioles) and the respiratory 
zone lined with alveoli where gas is exchanged. The pseudostratified epithelium 
lining the airways features ciliated and non-ciliated columnar cells, and 
. , 
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interdispersed goblet cells among a variety of other cell types (Figure 1 .1 ). 
Together with the submucosal glands, the goblet cells secrete mucus onto the 
epithelial surface, forming a blanket over the tops of the ciliated cells. This 
airway surface liquid (ASL) is composed of two layers that aid in ciliary 
movement that powers foreign material up and out of the lungs. The thick mucus 
layer of the ASL acts to bind and trap inhaled particles, and the underlying 
periciliary layer, which is less viscous, allows the cilia to move and push the 
mucus up the respiratory tract. Proper innate immune function of the conducting 
airway depends on this mucociliary escalator to clear the ASL containing inhaled 
particulate matter. 
Airway Surface Liquid 
-:--. -. -=----=--. -.--. -.-:.:-.---:---r----..---.~ .. -Mucus layer 
-Periciliary layer 
Goblet cell Basalcell 
Basement membrane 
- Submucosal gland 
Figure 1.1: Epithelium of the conducting airway. The conducting airway 
epithelium is composed primarily of ciliated cells and mucus-producing 
goblet cells. Inhaled particulates are entrapped in the airway surface liquid 
produced by the goblet cells and submucosal glands. Coordinated ciliary 
movement propels the airway surface liquid out of the airway. This 
mucociliary escalator is responsible for particle clearance in the conducting 
airways. Adapted from (Leff and Schumacker, 1993) . 
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With about 10,000 - 30,000 L of air breathed in per day, the lungs and 
airways are unavoidably exposed to particulate matter in addition to the oxygen 
and other gases in the atmosphere. The deposition of smaller particles like 
ENPs occurs in all regions of the respiratory system and depends on their size, 
shape, and ventilation parameters (Marijnissen and Gradon, 2010). Particle 
diameter is a primary factor in determining the mechanism of pulmonary 
deposition in the different regions of the respiratory tract, with smaller particles 
deposited in the smaller airways and alveoli as opposed to the larger airways 
(Carvalho et al., 2011 ). Other factors including solubility and viscosity of the 
material can alter this distribution. 
Particle deposition in the lungs occurs by impaction, sedimentation, and 
diffusion (Figure 1.2A) (Carvalho et al., 2011 ). The first mechanism of 
deposition, impaction, increases with particle size and air velocity, and is most 
influential in the head or extrathoracic region, where large particles travel at high 
velocities and tend to impact the respiratory tract. Particles deposited due to 
sedimentation are influenced mostly by gravity. This type of deposition increases 
with particle size and decreases with air velocity. Therefore, sedimentation is 
most prominent in the smaller airways and the alveoli (Nordberg et al., 2007). 
Deposition by diffusion occurs when particles are small enough to undergo 
random motion due to air molecules interacting with the inhaled and exhaled air, 
and has most effect when particles are nano-sized (smaller than 100 nm) 
(Marijnissen and Gradon, 2010). As particle size decreases to submicron 
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form tight junctions, maintain transepithelial resistance, and display vectorial ion 
transport (Cozens et al., 1994 ). Because the cells of the airways are one major 
target of inhaled particles and may be a significant site of absorption, this cell 
model was used to evaluate interactions between ENPs and the bronchial 
epithelium. 
1.3.3 Skin structure and ENP exposure 
Nanomaterials are present in wound dressings, drug delivery, cosmetics, 
detergents, food packaging, and other consumer goods. Topically applied ENPs 
are used in over 200 commercially available personal care products (Wiesenthal 
et al., 2011 ). Therefore, occupational and consumer settings also pose risk for 
ENP exposure through the skin. However, interactions between ENPs and 
human skin exposure remain largely unexplored (Crosera et al., 2009). 
The skin is composed of three layers: the hypodermis which is composed 
primarily of adipose cells; the dermis, which provides structural support and is 
made up of connective tissue; and the epidermis, which is the outermost layer 
and performs the fundamental barrier function of the skin. This epithelial layer is 
multilayered, composed largely of keratinocytes, and is self-repairing and 
continually renewed. The basal layer of the stratified epithelium is composed of 
keratinocyte stem cells that divide to give rise to transient amplifying (TA) cells. 
These TA cells can differentiate as they move upwards in the epidermis. In this 
way, they move through the prickle cell layer, the granular layer and towards the 
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1.4 Determinants of ENP toxicity 
1.4.1 The effect of ENP size 
The most obvious focus of ENP toxicity studies is on their size, which is in 
the range of typical cellular components and proteins, potentially allowing them to 
cross biological barriers and cause adverse or beneficial effects (Pan et al., 
2007). Also, because ENPs occupy less volume than larger particles, they 
present a larger number of particles with a greater surface area per unit mass 
and increased potential for biological interaction (Oberdorster et al., 2005). 
Therefore, many studies have investigated the relationship between ENP size 
and toxicity. 
One study examined the relationship between size and cytotoxicity of gold 
nanoparticles, which are used in biomedical imaging and diagnostic tests. Pan et 
al. exposed epithelial cell cultures to Au clusters between 0.8 to 15 nm. They 
found that Hela cells (human epithelial carcinoma cell line) formed tight 
monolayers in the absence of the Au compounds, but those exposed to Au 
compounds showed membrane blebbing and vesicle formation at the plasma 
membrane following only one hour of exposure. After 12 hours, the cells were 
significantly swollen with fragmented nuclei, and many had lost both cell-to-cell 
and cell-to-substrate contact. Furthermore, particles 1-2 nm in size were highly 
toxic, whereas larger 15 nm particles were comparatively nontoxic, showing a 
clear relationship between size and toxicity (Pan et al., 2007). 
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However, there is not a consistent size-dependent cytotoxicity of ENPs 
among studies or even among ENPs. For example, a separate study showed 
three different sized SiO2 nanoparticles had no difference in cytotoxicity (Cha and 
Myung, 2007). Additionally, there is considerable debate on the best dose metric 
for comparing different ENPs (Oberdorster, 2010). Both surface area and ENP 
number have been investigated; however, a more precise measurement for 
toxicity dose may be the biologically available surface area or surface reactivity 
(Oberdorster, 201 O; Wittmaack, 2007). In order to approach this issue in our 
studies, calculated surface area concentrations (based on the measured mass 
concentrations exposed to cell cultures) were examined in relation to observed 
toxicity effects on 16HBE14o- cells. 
1.4.2 Importance of ENP characterization 
It is important to characterize the physicochemical properties of ENPs, 
such as size, distribution, shape, agglomeration, surface properties, solubility, 
and crystal structure, that may influence their toxicological activity (Oberdorster, 
2010). A study on well-characterized metal oxide nanoparticles of similar nano-
sizes instilled into lungs of rats showed varying inflammation responses to the 
ENPs. Of the ENPs tested that were inflammatory (CeO2, NiO, ZnO, and CuO), 
each caused a different type of inflammation, indicating that the nano-size is but 
one of the characteristics that lead to inflammation (Cho et al., 2010). It is 
becoming increasingly clear that some combination of physical and chemical 
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features of individual ENPs is necessary to determine their intrinsic properties 
and biologic effects (Peralta-Videa et al., 2011 ). 
A range of analytical techniques can be used to distinguish the structure 
and morphology for ENPs. Morphological characterization and size 
determination is commonly determined by transmission electron microscopy 
{TEM). Alternatively, the crystal structure can be obtained by powder X-ray 
diffraction (XRD) (Park et al., 2010). Spectroscopic related techniques are also 
used in ENP characterization. Dynamic light scattering (DLS) can be carried out 
in aqueous solution (as opposed to TEM which is performed in a vacuum) to 
determine the size distribution, aggregation condition, and electrophoretic 
mobility of ENPs (Peralta-Videa et al., 2011 ). DLS is employed to estimate the 
ENP dispersion through the attraction or repulsion between particles. Another 
measurement used to describe the aggregation of particles in solution is the zeta 
potential. A zeta potential is generated when charged particles are dispersed in 
a medium, and is a measure of the potential difference between the dispersion 
medium and the surface of the layer of fluid attached to the dispersed ENP. It 
can be related to the stability of the ENP dispersion, i.e. particles with a low zeta 
potential (negative or positive) tend to agglomerate, while those with a high zeta 
potential are stable dispersions (Thielbeer et al., 2011 ). Another mass 
spectrometry method, time-of-flight secondary-ion mass spectrometry (ToF-
SIMS), is used to analyze surface chemistry, providing molecular information 
about the functional groups on the ENP surfaces (Baer et al., 2010). 
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1.4.3 Synthesis and life cycle of ENPs 
Since the structure and form of an ENP is important to its function, there is 
an emphasis on the control of experimental conditions to produce uniform size, 
distribution, shape, chemical composition, and structure, and also to avoid 
agglomeration in the production of ENPs for most applications (Ju-Nam and 
Lead, 2008). There are many different methods to produce and control these 
parameters. ENPs can be generated directly from bulk materials with machining 
and etching methods like photolithography and laser-beam processing, or 
mechanical techniques like grinding and polishing. These techniques are termed 
"top-down" methods and deal with the reduction in structure sizes of microscopic 
elements to the nanometer scale in order to ultimately make electronic devices, 
computer chips, and microelectromechanical systems (MEMS) (Byrappa et al., 
2008). Subsequent stabilization of the metal ENPs is usually obtained by adding 
colloidal protecting agents (Zhou et al., 2009). "Bottom-up" methods of synthesis 
control assembly of atomic and molecular aggregates into larger systems using 
chemical synthesis, self-assembly, and positional assembly (Byrappa et al., 
2008). Stabilizers such as surfactants are necessary to control the initial growth 
of nanoclusters and to prevent agglomeration (Zhou et al., 2009). Typical 
products of these techniques are cosmetics, fuel additives, crystals, and displays 
(Byrappa et al., 2008). It is interesting to note that these distinct processes can 
introduce quite unique contaminants to the ENPs. 
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An active area of research is to refine nanoparticle processing methods to 
better synthesize ENPs with predictable and controllable properties. Chen and 
Gao used a novel and low-cost route to synthesize well-dispersed Sn02 ENPs 
via a water-in-oil microemulsion-assisted hydrothermal process. In this process, 
the Sn02 ENPs were created to specification for gas-sensing applications (typical 
of metal oxide semiconductors) from precursor inorganic tin salts (Chen and 
Gao, 2004 ). These refined synthesis methods are important for biomedical 
applications that usually require strictly controlled ENP size and morphology, e.g. 
in systems that control precisely the activity and drug delivery by the ENP. A 
secondary effect of changing synthesis methods is that ENP surface 
characteristics can be modified, which can impact the toxicity effects of ENPs. 
No matter the processing method, ENPs can be released to the 
environment and exposed to humans. During ENP production and product 
manufacturing, workers can be directly exposed to ENPs through direct release 
or through the handling of dry powders. Workers involved in production of ENPs 
or ENP-containing products are at greater risks of exposure (inhalation and 
dermal) if powders are handled in non-enclosed systems, aerosols of ENPs are 
generated, ENP-containing materials are machined, sanded or drilled, or if 
maintenance and cleaning of production systems disrupts deposited ENPs. 
Exposure and environmental release can also occur during the life of the ENP-
containing product, including use, recycling, and disposal. Human exposure to a 
wide variety of ENPs, either directly, or indirectly through the environment, is 
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possible in many ways. Although there is a lack of occupational exposure 
measurements and environmental ENP concentrations, it is important to study 
the toxicology of these newly produced particles. The variety of applications of 
ENPs provides many opportunities for human exposure, including during 
manufacturing processes, disposal of wastes, and use of the products. 
1.5 In Vitro Models of ENP exposure 
Since the applications of ENPs are rapidly growing, more and more ENPs 
are being produced, and humans are increasingly exposed to ENPs in both 
occupational and medicinal situations. With this increased exposure, it becomes 
necessary to carefully assess the toxicology of these emerging ENPs, as well as 
their interactions with biological systems. The EPA has recognized the risk of 
nanomaterials to human health and has established an international collaborative 
project engaged in identifying alternative test methods for nanotoxicology. This 
effort is focused on establishing in vitro and other alternative methods for 
reduction, refinement, or replacement of animals in tests (EPA, 2011 ). Although 
in vitro systems are limited to one cell type (or a combination of a few) and 
therefore may not properly replicate interactions between a variety of cell types, 
they are easy to use, control, and interpret for cytotoxicity studies. With the 
quickly increasing numbers of potentially toxic ENPs that need to be tested, in 
vitro models are essential to assess the hazards of these materials (Stone et al., 
2009). 
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1.5.1 Toxicity Testing Methods 
There are a variety of in vitro assays used to obtain toxicity data. This 
section is not meant to be an exhaustive resource, rather an introduction to some 
of the most commonly used in vitro toxicity assays, including those utilized in this 
thesis. Additionally, it is thought that the discussed assays best reflect the ability 
of ENPs to induce toxic effects on humans. 
A common in vitro assay is based on 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) color changes. MTT is a tetrazolium salt that 
reduces to formazan in metabolically active (i.e. healthy) cells. In the 
mitochondria, dehydrogenases cleave the tetrazolium ring, yielding purple MTT 
formazan crystals, which are dissolved with detergent. The purple product can 
then be quantified by light absorbance. Based on cell type-specific relationships 
that associate an increased absorbance to an increase in cell number, cell 
number and viability can be determined to detect changes in proliferation and 
cytotoxicity. 
Another common, non-fluorescent system used to evaluate toxicity to cells 
is the lactate dehydrogenase (LDH) assay based on membrane damage of dead 
cells. LDH is a stable enzyme found in the cytoplasm of all cell types, but is 
released into the cell culture medium upon damage to the plasma membrane, an 
indicator of a reduction in cell viability. Assays that detect increased LDH in the 




Fluorescent-based cell viability assessment can also be used to 
simultaneously determine live and dead cells after exposure to ENPs. One of the 
most common microscopy-based fluorescent assays is the "Live/Dead" assay 
(lnvitrogen). This assay utilizes the membrane-permeant calcein-acetomethoxy 
ester (calcein-AM), which is cleaved by non-specific esterase activity in live cells, 
yielding a cytoplasmically trapped green fluorescence (ex/em ~495 nm/~515 nm) 
dye (calcien). Calcein detection of live cells is coupled with the charged and 
membrane impermeant ethidium homodimer-1 (EthD-1 ). This dye can enter 
membrane-compromised cells (i.e. dead cells) and interact with nucleic acids to 
display a "red" fluorescence (ex/em ~495 nm/~635 nm). Upon excitation with 
495 nm light, live cells (i.e., ones with intact plasma membranes and active 
esterases) appear green and dead cells (i.e., ones with compromised plasma 
membranes that allow for passage of EthD-1) appear red. The ratio of green to 
red cells within a population can be used as a quantitative measure of 
cytotoxicity. 
A disadvantage of fluorescence-based assays is that there is a potential 
for fluorescence interference with the ENPs and assays require analysis at 
individual time points. However, cell-based label-free technologies are available 
to assess cytotoxic responses over time. By avoiding the use of fluorescent 
dyes, these assays allow the cells to grow and act in their native environment 
without any potential negative effects of a label that could influence cellular 
processes. Furthermore, they produce real-time kinetic measurements by 
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monitoring the cells for the entire span of the experiment, instead of just a 
snapshot of the chosen endpoint. Therefore, in addition to the fluorescent 
Live/Dead assay, we utilized the Roche xCELLigence real time cell analyzer 
(RTCA) system to examine the cytotoxicity of ENPs to cell cultures. The RTCA 
system is based on electronic detection of biological assay processes. 
Microelectronic cell sensor arrays, which measure the electronic impedance, are 
integrated into the bottom of 96-well plates (E-plate). The RTCA system 
measures the electronic impedance of the sensor electrodes, allowing changes 
in cells on the electrodes to be detected and monitored. Cell viability, cell 
number, cell morphology, and degree of adhesion can affect electrode 
impedance. Relative changes in electrical impedance are expressed by the 
dimensionless "cell index" parameter, which is derived by dividing the impedance 
change by a background value. When cells are introduced into the wells of the 
E-plate, they make contact with and attach to the sensor electrode surfaces. The 
sensors are monitored with the RTCA Station, which may be placed inside a 
tissue culture incubator to allow for normal cell growth conditions. With the 
RTCA system, cell index can be monitored during cell growth and experiments to 
provide quantitative information about the biological status of the cells. We 
developed optimal conditions for RTCA experiments that test ENP cytotoxicity to 
both of our cell models (HaCaT and 16HBE14o-), as well as for experiments that 
examine cell-signaling responses of 16HBE14o- cells. 
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1.5.2 ENP Dosimetry 
There is significant discussion and lack of agreement on the best method 
for ENP dosimetry in toxicity studies: mass, number, and surface area measures 
have all been used to describe exposure, or administered ENP doses to cells. 
Not only are exposure doses inconsistently represented among studies, but they 
also have failed to produce in vitro systems that can predict an in vivo response, 
possibly because these exposure doses are not reliable measures of target cell 
dose across particle size or systems (Teeguarden et al., 2007). Exploring the 
relationship between dosimetry and toxicity or biological responses is important 
both to scale data across studies and to evaluate how the intrinsic surface 
chemistry of the material changes as the material approaches the nanoscale. 
Since ENPs settle, diffuse, and agglomerate, they do not act the same as 
soluble chemicals. Therefore, we cannot assume that the same administered 
ENP dose will give consistent cellular doses in in vitro systems across particle 
types with varying size, density, and physicochemical properties. Settling and 
diffusion rates of ENPs dependent on particle properties could greatly affect 
transport rates to the cell (Figure 1.4 ), and consequently affect relative toxicity 
(Hinderliter et al., 2010). A better measure would be a more direct cellular dose, 
but this is often difficult to quantify experimentally. Instead, Hinderliter et al. 
proposed a computational model that accounts for the dynamics of particles in 
liquids to describe the influence of diffusion and gravitational settling on particle 
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transport to cells in vitro (Hinderliter et al., 2010). The In vitro Sedimentation, 
Diffusion and Dosimetry model (ISDD) is based on the principles of Stokes 
sedimentation and Stokes-Einstein diffusion and calculates, based on inputs that 
are easily available (temperature, media density and viscosity, media height, 
hydrodynamic particle size, and particle density), a delivered dose to the cell. 
This cellular dose is a measure of particles associated with the cell, either on or 
in the cell. The ISDD model can also account for agglomeration of ENPs by 
incorporating agglomerate sedimentation velocity. 
Using a method like ISDD to consider system kinetics and obtain a more 
accurate measure of the ENP dose delivered to the target tissue will better allow 
particle types and doses to be compared among studies. In the current work, we 
used this model to examine the time course in which the tested ENPs are 
delivered to the cell cultures, demonstrating that parameters such as media 
height and particle size affect the fraction of administered dose that is deposited 
onto the cells. When comparing cytotoxicity of particles across studies, it is 
important to consider these diffusion and sedimentation determinants with 
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Figure 1.4: Transport rates of nanoparticles in vitro are affected by 
transport processes such as diffusion and sedimentation. Transport is 
controlled mostly by diffusion for particles ::5 ~10 nm and is controlled by 
sedimentation for particles greater than ~200 nm. Transport is fast when 
one mechanism dominates, but becomes slower when neither diffusion nor 
sedimentation is particularly effective (particles sizes between 10 and 100 
nm). Reprinted with permission (Creative Commons Attribution License) 
(Hinderliter et al., 2010). 
1.5.3 Nanoparticle interactions with the dispersion medium 
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The physicochemical properties of the ENPs contribute to the dynamic 
interactions between the ENP surface and the biological medium, including 
• 
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formation of a protein corona (Figure 1.5). When ENPs enter a biological fluid, or 
in the case of in vitro studies, a dispersion medium, their composition can be 
affected by the proteins of the medium that come in contact with the ENP 
surface. Proteins that coat the ENP make up the protein corona and they 
influence the ENP surface properties, charge, aggregation tendencies, and 
hydrodynamic size. The protein corona is associated with how the ENPs interact 
with cell membranes and receptors (Nel et al., 2009). These interactions can 
influence the cytotoxicity of an ENP and potentially lead to either more 
biocompatible or more bioadverse outcomes. This is particularly important to 
consider for in vitro assays, since the interaction of ENPs with serum in the 
suspension media can significantly affect their resultant toxicity in vitro (Clift et 
al., 2010). Therefore, ENP properties should be assessed in the dispersion 
medium used for in vitro experiments, since properties like hydrodynamic size 
can change once suspended in the medium. In our studies, we examined the 
size of Hf02 ENPs in different mediums, and found that the particle size 
distribution of this metal oxide ENP varies significantly depending on suspension 
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Figure 1.5: The protein corona surrounding an ENP can influence 
cytotoxicity effects. ENP characteristics determine the formation of the 
corona in the biological environment. Reprinted by permission from 
Macmillan Publishers Ltd: Nature Materials, (Nel et al., 2009), copyright 
2009. 
1.5.4 The effect of ENP exposure on cell signaling 
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Although it is important to determine the toxicity parameters of newly 
developed ENPs, it is also necessary to investigate the cellular and molecular 
mechanisms that lead to this toxicity. Previous research into air pollution, 
mineral dust particles, and diesel exhaust particles (DEP) provides a starting 
point for potential mechanisms of toxicity that lead to lung injury. For instance, 
ultrafine particles in air pollution ( <100 nm) have been shown to cause oxidative 





changes in intracellular Ca2+ signaling (Baulig et al., 2003; Donaldson and Stone, 
2003). Similar reactions have been shown for ENP exposure. For example, 
cultured cells exposed to cerium oxide and silica nanoparticles show an increase 
in reactive oxygen species (ROS), a decrease in the antioxidant glutathione 
(GSH), as well as other signs of oxidative stress (Akhtar et al., 2010; Park et al., 
2008). 
A three-tiered stress model has been proposed to explain cellular 
responses to increasing levels of stress caused by ENPs (Xia et al., 2008). In 
the Tier 1 level, low levels of stress produce protective cellular responses, e.g. 
anitoxidant enzymes induced to combat ROS. Tier 2 stress levels, however, can 
cause damaging effects that do not yet cause cell death, including alterations in 
cell signaling, innate immune responses, and transcription. The third tier of the 
model involves stress levels that cause cell death, either by apoptosis or 
necrosis. 
Many ENP toxicity studies demonstrate dose-dependent effects using 
cellular models, but most of these use exposure concentrations that are much 
greater than realistic human exposure scenarios. These high concentrations 
likely approach Tier 3 of the stress model in order to cause cytotoxicity. 
However, even if low ENP exposure levels do not kill cells, this does not mean 
that the cells are not affected. For example, A549 human alveolar cells cultured 
with alveolar macrophages exposed to benign concentrations of aluminum ENPs 
showed impaired phagocytic function and altered immune response activation. 
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This demonstrated that although the ENPs were not toxic to the cells, they did 
impair the cell's innate ability to respond to a respiratory pathogen (Braydich-
Stolle et al., 2010). These affects fall under the Tier 2 level of stress outlined by 
the hierarchal stress model (Xia et al., 2008). 
Autocrine/paracrine purinergic (ATP) signaling is an important part of 
cellular coordination in the airway epithelium. For example, purinergic signaling 
in the airway epithelium can mediate responses to bacteria and oxidative stress 
(Ahmad et al., 2006; Boots et al., 2009), and alterations in airway ATP signaling 
have been linked to chronic lung diseases like COPD (Lommatzsch et al., 2010). 
Coordinated Ca2+ signaling, mediated by ATP, is also important in lung defense 
strategies, e.g. ATP signaling can regulate intracellular Ca2+ concentration 
([Ca2+]i) to increase ciliary beatfrequency (Lieb et al., 2002). 
The intracellular messenger Ca2+ is extremely versatile and universal, and 
is involved in diverse cellular regulation in almost all cell types throughout their 
lifetime. The Ca2+ ion precisely regulates multiple functions, including triggering 
fertilization, controlling development and differentiation, and diverse cellular 
functions. Ca2+ signaling outcomes depend on increased levels of [Ca2+]i that 
can originate from outside the cell or from sources inside the cell, including the 
endoplasmic reticulum stores. Duration, location, and amplitude are all 
parameters of the Ca2+ signals that affect the coordination of complex 
physiological processes (Berridge et al., 1998). 
' 
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Any disturbance in these Ca2+ signals can modify the physiological outcome 
to affect normal cell functions. Oxidative stress has been shown to impact Ca2+ 
signaling, and has been examined in relation to nanoparticle exposure and cell 
viability. Human lung epithelial cells (BEAS-28) exposed to ZnO ENPs 
demonstrated cytotoxicity, while showing elevated oxidative stress and increased 
[Ca2+]i levels in a time- and concentration-dependent manner. The elevation in 
[Ca2+]i was partially attenuated by the antioxidant N-acetylcysteine (NAC), linking 
oxidative stress to disrupted Ca2+ homeostasis (Huang et al., 2010). These 
[Ca2+]i disruptions are seen even at non-cytototoxic concentrations of ZnO 
nanoparticles (Wang et al., 2010). These studies indicate that the cellular 
response to ENPs alter Ca2+ signaling. 
We hypothesized that ENP exposure to the airway epithelium could 
compromise innate immunity functions even at benign ENP levels. Therefore, in 
the present study, human bronchial epithelial cells were exposed to non-cytotoxic 
concentrations of ENPs, and their response to extracellular ATP was 
investigated. Indeed, these benign concentrations of ENPs caused reductions in 
cellular responses to ATP and reductions in Ca2+ signaling in response to ATP. 
1.6 Summary 
From the limited ENP studies available, it is evident that many ENPs 
cause negative health effects, including lung and airway-specific compromise 
following inhalation of the particles. Despite the rapidly increasing number of 
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ENPs being produced and exposed to humans and the environment, coordinated 
toxicity assessments are not currently in effect. In vitro techniques that model in 
vivo events are imperative to test the toxicity of new ENPs and to better 
understand their mechanisms of action. In the present study, cell cultures were 
used to assess metal oxide ENP toxicity to skin and lung epithelium. A real time 
cell analysis (RTCA) cytotoxicity assay was developed to build upon the toxicity 
data collected from an endpoint Live/Dead assay. Where minimal ENP toxicity 
was seen, it was hypothesized that cellular functions of innate immunity are 
disrupted by ENP exposure despite a lack of cell death. Therefore, the effect of 
ENP exposure on purinergic signaling was investigated. RTCA and intracellular 
calcium imaging were used to test the effect of ENP exposure to lung epithelium 
on the cellular response to ATP. 
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CHAPTER 2 - MATERIALS AND METHODS 
2.1 Materials 
Minimum essential medium with Earle's salts (MEM), Dulbecco's modified 
Eagle's medium (DMEM), Lechner and LaVeck (LHC) basal medium, Hanks' 
balanced saline solution (HBSS), penicillin, and streptomycin were purchased 
from lnVitrogen Corporation (Carlsbad, CA). Fibronectin and type I collagen 
were purchased from Becton-Dickinson (Franklin Lakes, NJ). GlutaMax, fetal 
bovine serum (FBS), and ATP were purchased from Sigma-Aldrich (St. Louis, 
MO). E-plates were purchased from Roche Applied Sciences (Indianapolis, IN). 
Fura 2-acetoxymethyl ester (fura 2-AM) and fura-2 were purchased from 
Calbiochem (La Jolla, CA). 
2.2 Nanoparticle sources 
All batches of HfO2 were obtained as dry powders. HfO2 batch 1 
(manufacturer reported size of 20 nm) and HfO2 batch 2 (manufacturer reported 
size of 2 nm) were a gift from Cornell University, Dept of Material Science and 
Engineering, Ithaca NY, USA. Batch 2 contained 10% wt/wt acetic acid. HfO2 
batch 3 (manufacturer reported size of 100 nm) of 99.9% purity was acquired 
from American Elements Co, Los Angeles, CA, USA. A reference micron size 
HfO2 (manufacturer reported size of <44 µm) of 99.95% purity was obtained from 
Alfa Aesar Co, Ward Hill, MA, USA. CeO2 (manufacturer reported size of 50 nm, 
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99.95% purity) and SiO2 (manufacturer reported size 10-20 nm, 99.5% purity) 
nanoparticles were obtained from Sigma Aldrich (St. Louis, MO, USA). 
Reference micron size SiO2 (manufacturer reported size <5 µm, 99.995% purity) 
and micron size CeO2 (powder, 99.9% purity) were also obtained from Sigma 
Aldrich. 
2.3 Particle size distribution (PSD) and zeta potential measurements 
PSD and zeta potential measurements were made in the laboratories of 
Ors. Reyes Sierra-Alvarez and Jim Field, University of Arizona by Antonia Luna 
and Lila Otero Gonzalez. The zeta potential of ENPs dispersions was measured 
with a Zeta Sizer Nano ZS (Malvern, Inc., Sirouthborough, MA) using laser 
doppler velocimetry (LDV). This technique uses a laser, which is passed through 
the sample, to measure the velocity of the particles in an applied electric field of a 
known value (electrophoretic mobility). The instrument uses the Smoluchowski 
equation to correlate particle electrophoretic mobility to zeta potential. PSD 
measurements were determined by dynamic light scattering (DLS) using the 
same instrument. The unit employs a 4mW He-Ne laser (633 nm) and a 
measurement angle of 173°. The refractive indices used for CeO2, Si 02, AbO3, 
and HfO2 were 1.828, 1.487, 1.765, and 1.990, respectively. Laser diffraction 
was performed by an outside lab to determine PSD measurements for micron-
sized HfO2 and SiO2. Particles were analyzed in a water dispersion using a 
Mastersizer Hdyro 2000S (Malvern Instruments, Ltd.). 
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2.4 Transmission electron microscopy 
Transmission electron microscopy (TEM) was performed by Antonia Luna, 
University of Arizona. ENP samples were examined by TEM to gain information 
on particle morphology and size. A Hitachi H8100 TEM instrument was used at 
200 keV. Its point-to-point resolution is 2 A for the high-resolution pole piece and 
2.3 A for the analytical pole piece. 
2.5 Cell culture 
The HaCaT human kerotinocyte skin cell line was a kind gift from Dr. Anne 
Cress (Dept. Cell Biology and Anatomy, University of Arizona). Cells were grown 
in full growth medium that consisted of DMEM supplemented with 10% (v/v) FBS, 
penicillin, and streptomycin at 37°C in a 5% CO2 atmosphere. Growth medium 
was replaced every other day until the cells reached confluence. Cells were 
expanded in flasks prior to passage onto 24-well plates for Live/Dead studies or 
96-well E-plates (Roche Applied Sciences) for assays using the xCELLigence 
real time cell analyzer (RTCA; Roche Applied Sciences). 
16HBE14o- cells are a SV40 transformed human bronchial epithelial cell 
line (Gruenert et al., 1995) and were obtained through the California Pacific 
Medical Center Research Institute (San Francisco, CA). 16HBE14o- cells were 
grown on a collagen/fibronectin bovine serum albumin (BSA) matrix (CFB; 88% 
LHC basal medium, 10% BSA, 1% bovine collagen type I, and 1% human 
fibronectin) in a full growth medium that consisted of MEM supplemented with 
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10% (v/v) FBS and 2 mM glutamax, penicillin, and streptomycin at 37°C in a 5% 
CO2 atmosphere. Growth medium was replaced every other day until the cells 
reached confluence. Cells were expanded in flasks prior to passage onto 24-well 
plates for Live/Dead assays, 96-well E-plates for RTCA studies, or onto 15 mm 
glass coverslips for microscopy studies. 
2.6 Live/Dead assay 
HaCaT cells were plated onto a 24-well plate at a density of 4,000 cells/cm2 
in full growth medium. The medium was replaced every third day until the cells 
reached confluence (4-7 d). Just prior to experimentation, the stock solution of 
ENPs was briefly sonicated, vortexed, and then diluted with HBSS (1.3 mM 
CaCl2, 5.0 mM KCI, 0.3 mM KH2PO4, 0.5 mM MgCl2, 0.4 mM MgSO4, 137.9 mM 
NaCl, 0.3 mM Na2PO4 and 1 % glucose additionally buffered with 25 mM HEPES, 
pH 7.4) to establish working concentrations. Cells were washed twice with HBSS 
to remove medium, and exposed to the appropriate concentration of HfO2 for 2 h 
at 37°C. Cells were then washed twice with HBSS, and subjected to the 
Live/Dead assay as per manufacturer's protocol (lnvitrogen). Wells were 
examined on an Olympus IX70 microscope using epifluorescence and a dual-
color cube. Six pre-determined areas from each well were captured, using a 
CoolSnap color camera (Roper Scientific, Tucson, AZ), and displayed on a 
Macintosh G4 computer. Total cells, live cells (green) and dead cells (red), were 
counted for each frame by a blinded observer and the percentage of live cells 
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representing each well were determined. A minimum of four wells were 
measured at each ENP concentration during each experiment. Live/Dead 
assays on 16HBE14o- cells were handled similarly, excepting that cells were 
plated in full growth medium at a density of 110,000 cells/cm2 onto 24-well plates 
coated with CFB. 
2.7 Cytotoxicity assay with Real Time Cell Analyzer (RTCA) 
16HBE14o- cells were plated in full growth medium at a density of 100,000 
cells/well (510,000 cells/cm2) onto 96-well E-plates (Roche Applied Science) 
coated with CFB solution. The cells were allowed to grow at 37°C in a 5% CO2 
atmosphere while relative impedance of each well was monitored in 15 min 
intervals using the RTCA device (Roche Applied Science). The RTCA measures 
relative impedance changes over time at the surface of each well to determine 
physiological changes in adherent cells that can be related to proliferation, 
cytotoxicity, or cellular signaling (Abassi et al., 2009). Relative impedance at any 
given time is expressed as "cell index." Cell index is defined as (Zi - Zo)/(15O), 
where Zi is impedance at a given time point during the experiment and Zo is 
impedance before the addition of the ENP. Average cell index for each ENP 
dose (n ~ 4) was graphed over time. The E-plate was removed from the RTCA 
and ENPs were added to the cell cultures when the average cell index reached a 
value corresponding to ~80% confluence, where 100% confluence is the cell 
index at which a plateau is reached. Cells were washed twice with serum-free 
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growth medium, and exposed to appropriate concentrations of the ENP being 
tested, then returned to RTCA at 37°C and 5% CO2. For continued cell index 
monitoring. RTCA cytotoxicity assays on HaCaT cells were handled similarly, 
except that cells were plated in full growth medium at a density of 15,000 
cells/well (76,400 cells/cm2) onto E-plates coated with poly-L-lysine. 
2.8 ATP Dose Response Curves Using RTCA 
16HBE14o- cells were plated onto a 96-well E-plate (Roche Applied 
Science) as indicated for the RTCA cytotoxicity assay, with cell index monitored 
in 15 min intervals overnight at 37°C and 5% CO2 by RTCA. At a cell index 
indicating ~40% confluence, full growth medium was replaced with full growth 
medium or full growth medium supplemented with the ENPs being tested, and 
the E-plate was returned to the RTCA at 37°C and 5% CO2 for continued 15 min 
interval monitoring of cell index. After 24 hr, the E-plate was removed from the 
RTCA, brought to room temperature, and then the cells were washed with HBSS 
with the appropriate ENP concentration. Increasing concentrations of ATP (100 
nM to 100 µM in ½ log steps, supplemented with the appropriate ENP 
concentration) were administered to the E-plate wells from previously prepared 
transfer plate wells. The E-plate was returned to the RTCA at room temperature 
immediately after ATP addition. Cell index was recorded in 15 sec intervals for 4 
hrs. Cell responses were collected from at least 4 wells and adjusted to a 
baseline by ratioing with recordings from cells washed with HBSS alone. Total 
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integrated cellular responses were calculated from the area under the curve for 
each ATP dose (Sherwood et al., 2011 ). 
2.9 Intracellular Ca2+ Concentration ([Ca2+]i) Measurements and ATP wash 
experiments 
16HBE14o- cells were plated in full growth medium (as previously 
described) at a density of 200,000 cells/well (110,000 cells/cm2) onto 15 mm 
glass coverslips. The medium was replaced every third day until the cells 
reached confluence (4-6 d). 24 hrs prior to experimentation, the medium was 
replaced with full growth medium or full growth medium supplemented with the 
ENPs being tested. Prior to imaging, 16HBE14o- monolayer cultures were 
washed with HBSS or HBSS supplemented with ENPs and then loaded for 40 
min in 5 µM fura 2-AM loading solution or fura-2AM loading solution 
supplemented with the appropriate concentration of ENP. Coverslips were 
returned to the appropriate HBSS solution for at least 20 min before Ca2+ 
imaging. Fura-2 fluorescence was observed on an Olympus IX70 microscope 
with a 40X oil immersion objective after alternating excitation between 340 and 
380 nm by a 75 W Xenon lamp linked to a Delta Ram V illuminator (PTI, London, 
Ontario) and a gel optic line. Images of emitted fluorescence above 505 nm 
were recorded by an ICCD camera (PTI) and simultaneously displayed on a 21" 
Vivitron color monitor. The imaging system was under software control 
(lmageMaster, PTI) and collected a ratio approximately every 0.6 sec. [Ca2+]i 
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was calculated by ratiometric analysis of fura-2 fluorescence using equations 
originally published in (Grynkiewicz et al., 1985). A typical experiment consisted 
of 20 sec of recording of cells in HBSS or ENP-supplemented HBSS to 
determine resting [Ca2+]i, followed by a ~10 s wash to apply ATP solution. Cells 
were monitored for an additional 160 sec. A change in [Ca2+]i was considered 
positive if the cell increased [Ca2+]i to 200 nM or more. 
2.10 Statistics 
Data were compared using a one-way ANOVA with Tukey's Multiple 
Comparison Test, unless otherwise noted. A value of P < 0.05 was used to 
establish significant difference between samples. 
± standard error of the mean (SEM). 
Figures are graphed 
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CHAPTER 3 - RESULTS 
3.1 Characterization of HfO2 ENPs demonstrates differences between 
manufacturer 
Differences in size and physicochemical properties of nanoparticles may 
affect their toxicity. To investigate how size affects toxicity, four batches of the 
same type of ENP, HfO2, from different sources were evaluated for average 
particle size, size distribution, zeta potential, and surface chemistry prior to 
examining the cytotoxicity of each batch. Previous studies have shown smaller 
particle size corresponds to increased surface area and therefore greater 
biological effects. Therefore, we hypothesized that smaller HfO2 ENPs would 
cause the highest levels of cytotoxicity. These characterization studies were 
carried out as part of a Semiconductor Research Corporation collaboration 
between Ors. Reyes Sierra-Alvarez, Jim Field, Farhang Shadman, and Scott 
Boitano, from the University of Arizona, and Dr. Buddy Ratner from the University 
of Washington (Field et al., 2011 ). 
The stated primary size of HfO2 batches 1, 2, and 3 were 20 nm, 2 nm, 100 
nm, respectively, and the micron HfO2 particles were reported to be <44 µm in 
size. (Figure 3.1, Table 1 ). Measurements to verify the sizes showed that the 
size reported by the supplier did not agree with the measured size for any of the 
batches. The measured particle size distribution (PSD) of samples 1-3 are 
shown in Figure 3.2, and the PSD of the micron batch is shown in Figure 3.3. 
( 
49 
The average hydrodynamic particle size of HfO2 ENPs dispersed in pH 4 dilute 
acetic acid was measured by dynamic light scattering (DLS) and ranged from 
150 to 286 nm for the nano-sized particles (Figure 3.2). Batch 3 samples had the 
lowest average size of 150 nm, but the PSD shows that a portion of the particles 
spans the nano-region (<100 nm) and were therefore considered "nanoparticles" 
in this study. The PSD of the micron HfO2 was measured with laser diffraction 
and had an average particle size of 6.768 µm, which agrees with the supplier-
reported size of <44 µm (Figure 3.3). Particle size measurements were also 
made with TEM and SEM images, but only batch 3 and micron HfO2 samples 
produced measurements with good correspondence between the DLS 
measurement. Agglomeration and crystal formation were visible in TEM images 
of batches 1 and 2 (Figure 3.1 ). 
Table 1: Particle size characterization of the different samples of Hf02 
ENPs. ENPs were suspended in 100 mg L-1 solution of acetic acid 
adjusted to pH 4, followed by ultrasonic treatment (130 W, 20 KHz, 60% 
amplitude) for 5 min and particle size was measured with dynamic light 
scattering (DLS), performed by Antonia Luna, University of Arizona. 
TEM/SEM ima es diameter nm 1000-5000 2000-8000 150-260 300-1000 
Zeta otential mV + 52 44 66 64 
PSD measured by laser diffraction in water dispersion using Mastersizer Hydro 
2000S Malvern (Sasol Italy R&D) 
·visible as agglomerates 





Figure 3.1: TEM images of each Hf02 batch used in this study. 
Particles of different batches varied in size and shape and displayed 
particle agglomeration. Average particles sizes did not agree with the sizes 
reported by the supplier (Table 1 ). Images were provided by Antonia Luna, 
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Figure 3.2: Particle size distribution of Hf02 ENP batches 1-3. Particle 
size distribution of the different batches of HfO2 ENPs based on light 
intensity. The sizes noted on inset legend refer to the manufacturer 
reported size. Samples were prepared in pH 4 in 100 mg L-1 acetic acid. 
Average diameters for each batch are shown in Table 1. Measurements 
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Figure 3.3: PSD for Hf02 micron batch. PSD for the HfO2 micron batch 
was analyzed with laser diffraction in a water dispersion with a Mastersizer 
Hydro 2000S Malvern (Sasol Italy R&D). Although the stated particle size 
was <44 µm , the measured volume weighted mean was 6.768 µm. 
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Since the medium used to suspend and administer the ENPs to the in vitro 
culture can potentially affect the PSD, ENPs of one Hf02 batch were dispersed in 
various media, and the PSD was measured for each dispersion. Batch 3 was 
the focus of further experiments in this study, and was therefore chosen for this 
comparison. PSD of batch 3 Hf02 ENPs was measured in Milli-Q water 
(ultrapure, deionized; Millipore), Milli-Q water with polyacrylate dispersant 
(Dispex), MTT medium (DMEM supplemented with 5% FBS), or HBSS at pH 7.2 
(Figure 3.4). Compared to the PSD in dilute acetic acid, the PSD of batch 3 Hf02 
was larger in Milli-Q water with an average 359 nm, indicating that the neutral pH 
causes agglomeration and a shift to larger average particle size. The addition of 
Dispex (a polyacrylate dispersant) to Milli-Q water reduced the PSD by reducing 
the interaction between the Hf02 ENPs. MTT medium also caused a decrease in 
PSD compared to Milli-Q water. HBSS, a balanced salt solution, as a dispersion 
medium greatly increased PSD, producing an average particle size of 3.242 µm. 
This increase may be due to the salts increasing the tendency of the NPs to 
agglomerate. The variation in agglomeration among suspension mediums 
emphasizes the importance of characterizing the size of particles in the medium 
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Figure 3.4: Particle size distribution of batch 3 Hf02 ENPs in different 
media (MQ-water, MQ-dispex, MTT, or HBSS) at pH 7.2. The dispersion 
medium can affect particle size. Particles in HBSS had the largest average 
particles size of 3,242 nm. Average particle size for each media is 
displayed in the legend. Measurements performed by Antonia Luna, 
University of Arizona. 
3.2 Characterization of SiO2 and CeO2 ENPs 
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In addition to comparing ENP size characteristics between batches of HfO2 
ENPs, silicon oxide (SiO2) and cerium oxide (CeO2) ENPs were examined. TEM 
images were used to visualize the particles (Figure 3.5) and DLS was used to 
determine the size distribution in aqueous solutions (Figure 3.6). CeO2 (reported 
size, 50 nm) had an actual average size of 132 nm, and SiO2 (reported size, 10-
20 nm) was 368 nm, as measured by DLS (Table 2). Similar to the findings with 





An important lesson is highlighted here, that data provided by the particle 
supplier should be reconfirmed prior to assessing their toxicity properties. Also , 
wet phase (DLS) measurements are likely reflective of agglomeration in the 
solvents. In future experiments, it would be imperative to accurately assess the 
sizes of the particles delivered to the cells in order to gain reliable relationships 
between particle size and effects on cells. 
Table 2: Particle size characterization of Si02 and Ce02 ENPs. 
Parameter Nano- Nano- Micron- Micron-
Si02 Ce02 Si02 Ce02 
Size reported by supplier 10-20 nm 50 nm powder < 5µm 
DLS/diffraction average diameter 368 ± 3 132 ± 1 212 ,800 ND 
(nmt 
Zeta potential (mV) -39.2 ± 0.3 44.5 ± 1.1 ND ND 
pH 7.32 3.40 ND ND 
ND indicates not determined 
·pH value of the dispersion tested for particle size distribution 
Figure 3.5: TEM images of (A) Ce02 and (8) Si02 used in this study. 
Ce02 ENPs were cube-shaped and Si02 were more typically spherical. 
Agglomeration appeared to be a potential problem. Images were taken by 
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Figure 3.6: Particle size distribution of (A) CeO2 and (8) SiO2 ENPs in 
aqueous solutions with pH values of 7.50 and 7.32, respectively. The 
size distributions span an entire log, showing large variation in particle size. 
Average particle sizes are listed in Table 2. Measurements were done by 
Lila Otero Gonzalez, University of Arizona. 
3.3 ENP cytotoxicity evaluations 
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Multiple assays were used to evaluate the cytotoxicity of ENPs. The 
fluorescent Live/Dead assay was used to investigate effects of select ENPs at 
single time points (2 hrs after exposure), and, once developed, the non-
fluorescent RTCA assay was used to examine ENP effects over time . 
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3.3.1 Cytotoxicity comparison between Hf02 from different suppliers with 
Live/Dead assay 
In order to relate the size characterizations of the four Hf02 particle 
batches to cytotoxicity, Live/Dead assays were performed on each batch. 
HaCaT cell cultures were exposed to the Hf02 ENP samples for 2 hr, and acute 
cytotoxicity was evaluated by determining the percentage of live cells in the 
culture. Figure 3.7 shows the percent live cells after the 2 hr exposure to each 
Hf02 batch. Batch 1 showed the highest levels of cytotoxicity to the HaCaT cells, 
causing almost a 50% decrease in live cells at a Hf02 concentration of 2000 
ppm. Batches 2, 3, and Micron only showed significant toxicity at high 
concentrations. Batches 2 and 3 only decreased live cells by approximately 10% 
at 2000 ppm compared to the control. The Micron batch was only significantly 
toxic at the highest concentration tested, 5000 ppm, showing a 25.7% relative 
decrease in live cells. 
These results show that for Hf02 particles, size is not a good predictor of 
cytotoxicity. Since batch 3 Hf02 particles had the smallest size, their lack of 
cytotoxicity was unexpected. Also, batch 1 Hf02 particles, which had the largest 
measured diameter, were clearly the most cytotoxic. The increased toxicity of 
batch 1 may be attributed to different surface contaminants. As part of the SRC 
collaborative effort to investigate these Hf02 particles, Dr. Buddy Ratner 
performed ToF-SIMS analysis on each batch of Hf02 particles in order to 
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evaluate surface contaminants that might be affecting toxicity. Since the particle 
batches came from different manufacturers, differences in contamination may 
arise due to different synthesis routes or environments that the particles are 
stored. The main finding from the ToF-SIMS analysis was that batch 1 HfO2 
particles showed a higher intensity bromine contamination than the other 
batches, possibly resulting from the synthesis pathway, which commonly uses 
Hf8r4 as a starting material. These high bromine levels may have contributed to 
the higher toxicity levels observed for batch 3 HfO2 particles (Field et al., 2011 ). 
To determine if the HfO2 ENPs have similar effects on 16HBE14o- cells as 
on HaCaT cells, a Live/Dead assay was performed on 16HBE14o- cell cultures 
exposed to batch 3 HfO2 for 2 hr (Figure 3.8). Consistent with the HaCaT results, 
only slight cytotoxicity was induced at the highest concentration tested, 2000 
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Figure 3.7: Live/Dead cytotoxicity assay on Hf02 batches shows 
minimal cytotoxicity to HaCaT cell cultures. HaCaT cells were cultured 
in 24-well plates in full growth medium and grown to confluence. Cell 
monolayers were exposed to appropriate concentrations of HfO2 in HBSS 
for 2 hr at 37°C. Batch 1 HfO2 exhibited the greatest toxici ty, with a 
significant decrease in percentage of live cells at 500 ppm HfO2. Batches 
2, 3, and Micron showed minimal toxicity only at the highest concentrations 
tested . Error bars represent SEM; * represents significantly different than 
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Figure 3.8: Batch 3 Hf02 ENPs are not cytotoxic to 16HBE14o- cells. 
16HBE14o- cells were cultured in 24-well plates in full growth medium and 
grown to confluence. Cell monolayers were exposed to appropriate 
concentrations of Hf02 in HBSS for 2 hr at 37°C. Minimal cytotoxicity was 
demonstrated towards 16HBE14o- cells, similar to batch 3 Hf02 toxicity 
towards HaCaT cells (Figure 3.5). Error bars represent SEM; * represents 
significantly different than the control culture exposed to Hf02-free HBSS 
(n = 4, P < 0.05). 
3.3.2 Real time cell analysis cytotoxicity assay development 
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Although the Live/Dead assay is effective for evaluating toxicity at a single 
time point, it is more beneficial to assess cellular responses to ENPs over 
extended periods of time. Live/Dead assays yield important information on 
cytotoxicity at single time points that are chosen for comparison studies. RTCA 
can improve on this approach by continually monitoring changes in cytotoxicity 
over extended times, up to 48 hrs. Thus, we repeated our ENP cytotoxicity 
assays using the RTCA device. Prior to performing RTCA toxicity assays, it was 
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necessary to determine the most appropriate medium and culture conditions in 
which to run the experiments. 
3.3.2.1 Initial cell density affects the rate of proliferation to a cell monolayer 
Cell cultures exposed to ENPs in the RTCA cytotoxicity assay were grown 
to ~80% confluence before ENP exposure in order to best represent an epithelial 
monolayer while allowing for continued growth and measurement during and 
after ENP exposure. The number of cells initially seeded on the RTCA E-plate 
influences the proliferation rate of the cells and the time that the culture becomes 
a confluent epithelium. We took advantage of the RTCA assay to monitor cell 
proliferation and determine a proper seeding density in which the cell index 
neither plateaus, nor increases too slowly, and forms a confluent monolayer 
within 24 hrs. To determine the most appropriate initial cell seeding density, a 
varying number of HaCaT cells (15,000; 20,000; or 40,000 cells/well) were 
plated, and cell ihdex was monitored over time (Figure 3.9). An initial HaCaT cell 
density of 40,000 cells/well showed the greatest proliferation rate, and cell index 
reached a plateau after approximately 8 hrs. Initial densities of 15,000 and 
20,000 cells/well had slower growth rates and continued to increase cell index 
even after 16 hrs. A density of 20,000 HaCaT cells/well was chosen for 
cytotoxicity experiments because it allowed cell index to near to confluence 
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Figure 3.9: Initial HaCaT cell seeding densities on E-plates for RTCA 
analysis affect proliferation rate. HaCaT cells were plated on 96-well E-
plates at densities of 15,000; 20,000; or 40,000 cells/well in full growth 
medium. The initial cell density of 40,000 cells/well showed the fastest 
growth rate of the tested initial densities, reaching a plateau at 
approximately 8 hrs. 
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Since different cell lines grow at different rates, an appropriate initial cell 
plating density for one cell type will not necessarily be appropriate for another. 
Therefore, a similar cell density experiment was also carried out for 16HBE14o-
cells, which were used as a model to investigate the cytotoxicity of ENPs on the 
airway epithelium. 16HBE14o- cells plated at a density of 100,000 cells/well 
increased faster than those plated at cell densities of 75,000 and 50,000 
cells/well (Figure 3.10). In order to mimic the wash and time point at which ENPs 
are applied to the cell cultures in a cytotoxicity experiment and to determine if 
washing on a buffer or ENP suspension medium affected the cell index, the cells 




the HBSS wash, there was a small increase in cell index, which then quickly 
recovered. The cell index of wells plated with 100,000 and 75,000 cells/well 
continued proliferating for ~5 hr, and then reached a steady plateau (after ~25 
hrs), indicating a steady impedance state likely reflective of decreased 
proliferation without cell detachment. 16HBE14o- cells seeded at 50,000 
cells/well showed minimal proliferation after the HBSS wash and experienced a 
slight decline in cell index ~40 hrs. Based on these results, we concluded that 
16HBE 140- cells plated at 100,000 cells/well will reach an appropriate 
confluence for a RTCA cytotoxicity experiment in less than 24 hrs. 
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Figure 3.10: Initial cell number affects cell proliferation rate and cell 
index stability after washing. 16HBE14o- cells were plated on 96-well E-
plates at densities of 50,000; 75,000; or 100,000 cells/well in full growth 
medium. At ~20 hr after plating, growth medium was replaced with HBSS. 
Initial cell densities of 75,000 and 100,000 cells/well showed increased 
proliferation rates compared to 50,000 cells/well and more stability of cell 
index after HBSS wash. 
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3.3,2.2 ENP suspension medium affects the cell index 
ENPs may act differently (e.g. alter agglomeration characteristics) in 
different suspension media. Therefore, buffers other than HBSS may be 
required for the optimum ENP suspension and delivery to the epithelial 
monolayer. We performed a series of experiments to determine if varying the 
suspension medium affected the cell culture. 16HBE14o- cells have been shown 
to be stable after washing with HBSS (Figure 3.10). However, if a different buffer 
(e.g. PBS) provides a more stable dispersion for the ENP, it should be tested for 
adverse effects on the cell culture as well. The cell index of 16HBE14o- cultures 
was monitored before and after being washed with either HBSS or PBS. 
16HBE14o- cells washed with HBSS maintained a steady cell index, whereas the 
cell index of those washed with PBS showed a large initial decline due to the 
PBS wash, and further decreased cell index after ~5 hrs after washing (Figure 
3.11A). Therefore, although PBS may provide a good dispersion medium for 
ENPs, it is not a good choice for the RTCA cytotoxicity assay. A similar 
experiment was performed on HaCaT cells to compare the RTCA response to 
buffer washes between cell types. A similar trend was seen in that the PBS 
wash caused a large decrease in cell index. However, the HBSS wash also 
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Figure 3.11: Cells washed with HBSS maintain cell index better than 
cells washed with PBS. Cells were plated on E-plates in full growth 
medium and allowed to grow for ~20 hr. Cells were washed with either 
HBSS or PBS solutions and cell index was monitored for an additional 20 
hr. (A) 16HBE14o- cells washed with HBSS maintained a stable cell index, 
while those washed with PBS showed an large initial loss of cell index and 
a further decline at ~30 hr. (B) HaCaT cells also showed a large decrease 
in cell index due to PBS wash. An HBSS washed caused a slight cell index 
decline to HaCaT cells as well. 
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3.3.2.3 Use of growth medium as an ENP suspension medium 
If the cells are allowed to proliferate to a confluent epithelium, and then the 
ENPs are administered in a suspension medium that is growth medium (instead 
of a buffer), the cell cultures would not experience the stress of changing media 
types. In addition to reducing stress to the cells, applying ENPs in growth 
medium would allow for an prolonged cytotoxicity assay, since the cells would be 
supplied the proper nutrients. However, since full growth medium contains 
serum (protein supplementation), ENP-protein interactions can lead to 
differences in dispersion and agglomeration of the ENPs within the medium, 
which could affect the potential toxicity effects. To first see if the presence or 
absence of serum in growth medium (MEM) affected cell growth, the growth 
medium was replaced after the initial proliferation with either the same full growth 
medium (supplemented with 10% FBS) or serum-free medium. Both groups of 
cells continued to show increasing cell index, although cells washed with growth 
medium without serum had a slightly slower growth rate that developed after 6-8 
hrs of medium exchange (Figure 3.12). For the first 6-8 hours after medium 
exchange, there was no significant difference between full and serum-free 
medium. Therefore, serum-free growth medium can be used as an ENP 
suspension medium to reduce the stress imposed on the cells and to extend the 
length of the experiment, as well as reducing the occurrence of ENP-protein 





reduced when dispersed in a growth medium, compared to an HBSS dispersion 
(Figure 3.4 ), which is beneficial for assessing the toxicity of the particles. 
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Figure 3.12: Cells washed with growth medium without serum 
continue to increase cell index, albeit at a slightly slowed rate. 
16HBE 140- cells were plated on E-plates in full growth medium at a density 
of 100,000 cells/well and allowed to grow for ~20 hr. After ~20 hr, cells 
were washed with either full growth medium supplemented with 10% FBS 
or serum-free growth medium. Cell index was monitored over time for ~25 
hr. Cells washed with growth medium supplemented with serum and cells 
washed with serum-free growth medium continued to show an increasing 
cell index over the 25 hr monitoring time. 
3.3.3 Evaluation of HfO2, CeO2, and SiO2 cytotoxicity with RTCA 
Once parameters for an RTCA cytotoxicity assay were determined, RTCA 
was used to evaluate the toxicity of HfO2 batches 1 and 3 (Table 1) to 
16HBE 140- cell cultures. Batch 1 was chosen due to its high levels of toxicity 
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seen in the Live/Dead assay, and batch 3 for its near-nanoparticle average size 
(150 nm). We found that batch 1 HfO2 ENPs induced significant cytotoxicity in 
16HBE14o- cells at doses of 300 and 500 ppm, as indicated by a decreased cell 
index. The cell index of cells exposed to 100 ppm batch 1 HfO2 did not vary 
significantly from the control (Figure 3.13A). These results agree with the 
findings of the Live/Dead assay, which assessed cytotoxicity after 2 hrs and 
showed significant toxicity when cells were exposed to 500 ppm batch 1 HfO2. 
Finally, we found HfO2 ENPs from batch 3 were not cytotoxic when applied at 
doses up to 5000 ppm (Figure 3.138). This is consistent with the lack of toxicity 
seen in the Live/Dead assay. Once again, we found the batch 3 HfO2 particles 
(average DLS size, 150 nm) did not induce more cytotoxicity than the larger 
batch 1 HfO2 particles (average DLS size, 286 nm). Therefore, we conclude 
there is not a direct correlation linking smaller ENP size to greater levels of 
cytotoxicity. However, the cell index traces of cells exposed to 3000 and 5000 
ppm batch 3 HfO2 show a sharp increase compared to the control during the first 
10 hrs, which is then recovered to the level of the control. This cell index 
increase due to high levels of HfO2 exposure is indicative of a cellular response 
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Figure 3.13: Hf02 batches 1 and 3 show different cytotoxicities. 
16HBE14o- cells were plated at a density of 100,000 cells/well and allowed 
to proliferate ~20 hr. Cells were washed with serum-free growth medium, 
exposed to appropriate concentrations of HfO2, and cell index was 
monitored over time. (A) Batch 1 HfO2 showed a decreased cell index 
indicative of cytotoxicity for 300 and 500 ppm (B) Batch 3 HfO2 did not show 
decreased cell index for even the highest concentration tested (5000 ppm 
HfO2). 
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In addition to comparing cytotoxicity between HfO2 ENP batches, toxicity 
was compared among other ENPs as well, under identical conditions. SiO2 and 
CeO2 were tested for cytotoxicity to 16HBE 140- cells with RTCA analysis . 




the doses tested (Figure 3.14A). Si02 ENPs, however, induced significant 
toxicity in 16HBE14o- cells at doses of 200 ppm Si02 and greater, as indicated 
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Figure 3.14: Si02 ENPs are cytotoxic and Ce02 ENPs are not. 
16HBE14o- cells monitored by RTCA were allowed to proliferate, and then 
exposed to Ce02 or Si02 ENPs ~20 h. (A) Cells exposed to Ce02 ENPs 
continued to grow, and all concentrations tested showed minimal deviation 
from the control. (B) Si02 ENPs demonstrated significant toxicity to cells at 
concentrations of 200 ppm and greater. Data obtained by Lila Otero 
Gonzalez, University of Arizona. 
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3.4 Effect of non-cytotoxic HfO2 on ATP signaling 
Since the ENPs examined induced minimal cytotoxicity (i.e., cell death) in 
16HBE14o- cells, and only at relatively high concentrations compared to ENPs 
that cause toxicity effects at concentrations under 100 ppm (Park et al., 2008), 
we next focused on how the ENPs might be affecting cellular signaling. The 
rationale behind these experiments is that although ENP exposure does not kill 
the cells, it may still interrupt and affect important cell signaling parameters, and 
thus have an adverse impact on cell function. For example, nanoparticle 
exposure has been shown to alter innate immune responses in the lung (Inoue, 
2011 ). Purinergic ATP signaling is an important part of the innate immune 
defenses of the airway epithelium. Local release of ATP can contribute to 
coordinating many diverse innate immune processes in the conducting airway, 
including ciliary beat, salt and water transport, and wound repair. Each of these 
processes can be downstream of ATP-induced Ca2+ signaling in airway epithelial 
cells. Therefore, we examined the effect of low, non-toxic concentrations of 
ENPs on the airway epithelial response to ATP using both RTCA and Ca2+ 
imaging. Because batch 3 HfO2 particles did not cause toxicity to airway 
epithelial cells in the RTCA assay, even at high exposure concentrations (Figure 
3.138), we used these particles to model non-toxic exposures. 
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3.4.1 RTCA assay shows exposure to HfO2 attenuates cellular response to ATP 
The RTCA assay was adapted to investigate the cellular response of 
16HBE14o- cells to exogenously applied ATP. After initial proliferation, cells 
were exposed to varying doses of batch 3 HfO2 (0 ppm, 50 ppm, or 250 ppm) for 
24 hrs. Cells grown in HfOrfree and HfOrsupplemented growth medium 
displayed similar cell index traces over the 24 hr exposure (Figure 3.15), which 
demonstrated these doses were non-cytotoxic and in agreement with the lack of 
cytotoxicity established by the fluorescent Live/Dead assay (Figure 3.8) and 
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Figure 3.15: Low doses of HfO2 batch 3 do not affect cell growth over 
24 hr exposure. 16HBE14o- cells were grown in MEM, which was replaced 
after ~23 hr with batch 3 HfO2 supplemented MEM (50 or 250 ppm). Cell 
index traces show that cell growth is not affected by 24 hr exposure to 
batch 3 HfO2 compared to the O ppm control. 
( . 
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After the 24 hr exposure, ATP was exogenously applied to the cells in 
varying doses (100 nM to 100 µM in ½ log steps) and caused a rapid, dose-
dependent increase in cell signaling as shown by a rapid increase in cell index 
(Figure 3.16A). 16HBE 140- cells exposed to both 50 ppm and 250 ppm batch 3 
HfO2 showed a diminished response to the applied ATP, seen by comparing both 
the peak response and the continued response over the 4 hr experiment (Figure 
3.168, C). Dose response curves based on cumulative response were 
calculated from the area under the curve. The response to ATP of cells exposed 
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Figure 3.16: Exposure to non-cytotoxic levels of HfO2 dampens 
cellular response to ATP. 16HBE14o- cells plated on E-plates were 
allowed to grow ~20 hr, then exposed to 0, 50, or 250 ppm batch 3 HfO2 in 
full growth medium for an additional 24 hours. ATP (0 - 100 µM in ½ log 
steps) was added to individual wells (shown as time 0; n=4 for each dose), 
and cell index was monitored over time. (A) ATP addition caused a rapid, 
dose dependent increase in cell signaling, which was (B) attenuated by 
exposure to 50 ppm batch 3 HfO2 and (C) 250 ppm batch 3 HfO2 relative to 
the control. (D) Total integrated cellular responses for each HfO2 exposure 
concentration were calculated from the area under the curve for the 4 hr 
experiment for each ATP dose (n=4) and plotted as percent of maximum 
response (i.e ., the value at 0 ppm HfO2 and 100 µM ATP) to obtain a dose 
response curve. Fitted curves are shown for comparison. Both 50 and 250 
ppm HfO2 exposures significantly reduced the response to ATP (two-way 
ANOVA; P < 0.0001 ). 
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3.4.2 HfO2 exposure reduces the Ca2+ response of human epithelial monolayers 
to exogenously applied ATP 
Application of exogenous ATP to airway epithelial cells can induce 
activation of many signaling systems, including the increase of [Ca2+]i in human 
airway epithelial cells. To evaluate if airway epithelial cells exposed to ENPs 
have an altered Ca2+ response, we monitored [Ca2+]i following exogenous ATP 
addition with digital imaging microscopy (Figure 3.17) (Sherwood et al., 2011 ). In 
16HBE14o- cultures that were not exposed to ENPs, ATP application induced a 
rapid increase in [Ca2+]i over the entire field of view, with approximately 44% of 
cells reaching a [Ca2+]i threshold level of 200 nM. Cell cultures exposed to non-
cytotoxic concentrations of HfO2, SiO2, and CeO2 ENPs for 24 hrs prior to ATP 
application showed a reduced response to ATP application compared to the 
control, with significantly fewer cells in the field of view reaching the 200 nM 
[Ca2+]i threshold (Figure 3.18A,B,C). Of the ENPs tested, exposure to SiO2 
ENPs caused the greatest decrease in [Ca2+]i response, with 71 % fewer cells 
responding after exposure to only 10 ppm CeO2, and 91 % fewer cells responding 
after exposure to 25 ppm CeO2 (Figure 3.18C). Exposure to SiO2 ENPs also 
caused significant reduction in [Ca2+]i response following exposure, showing only 
50% response compared to the control (Figure 3.188). HfO2 ENPs also affected 
the [Ca2+]i response to ATP, although significant differences were only seen at 25 
ppm exposures (Figure 3.18A). 
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Our studies showed that neither the nano-sized HfO2 nor the micron-sized 
HfO2 was significantly cytotoxic (i.e., caused cell death) to our cell cultures, 
indicating that smaller particle size does not directly relate to increased toxicity or 
biological effects. However, we hypothesized that smaller particles could have a 
greater effect on Ca2+ signaling than larger particles have. Therefore, we 
exposed 16HBE14o- cells to reference micron-sized particles of the same 
concentrations and 24 hr exposure time, and examined their [Ca2+]i response to 
ATP. Cell cultures exposed to the micron-sized HfO2, SiO2, and CeO2 particles 
still demonstrated reductions in [Ca2+]i response relative to the control following a 
24 hr exposure, although to a lesser extent than nano-sized particle exposure. 
SiO2, especially, did not cause a significant reduction in [Ca2+]i response even 
after 25 ppm exposure (Figure 3.18E). However, micron-sized HfO2 and CeO2 
particles did both cause significant reductions in Ca2+ signaling after exposure to 
concentrations of 50 and 25 ppm, respectively, showing that both micron- and 













Figure 3.17: Nano-Hf02 particles reduce ATP-induced Ca2+ response in 
human airway epithelial cells, visualized by single viewing fields of 
cells from cultures treated with or without Hf02 and monitored over 
time (3 min) for [Ca2+]i changes after the addition of 1 µM ATP. 
16HBE14o- monolayers were grown to confluence on coverslips. Cell 
monolayers were exposed to HfO2-free or HfO2-supplemented growth 
medium (50 or 250 ppm) for 24 hrs and subsequently monitored for [Ca2+]i 
changes in response to application of 1 µM ATP. Panels (B) and (C) show 
reduced [Ca2+]i changes compared to the control shown in panel (A). White 
lines approximate cell borders. The time following ATP wash is in the lower 
left of boxes. The color scale for [Ca2+]i is shown in the 0 sec time point of 







* 2 ::E C C: 
0 0 3 0 Q I 
<NJ <NJ 
" " t 2 j 2 
§1. 1 !/1. 1 a; aii 
0 0 
"' 
. ,/!_ . 
0 25 250 0 10 50 






c; *' c; 




" " t 2 i 2 




0 10 0 10 25 
C_ [N!a111to"8i.OJ (ppm) F [Microim-5102] (ppm) f:' 5 t' 5 
"' "' 2 2 4 







" " ,: 2 ,::, 2 1 'i * 





0 10 25 0 10 25 
~amo-CeOJ {ppm> [Micron-CeOz] (ppm► 
Figure 3.18: ENP exposure reduces ATP-induced Ca2+ response in 
human airway epithelial cells. 16HBE14o- monolayers were grown to 
confluence on coverslips. Cell monolayers were exposed to ENP-free or 
ENP-supplemented growth medium (varying from 10 to 250 ppm) for 24 hrs 
and subsequently monitored for [Ca2+]i changes in response to application 
of 1 µM ATP. Cell monolayers exposed to ENPs demonstrated a lower 
percentage of cells responding (by increasing [Ca2+]i to >200 nM) to ATP. 
Graphs show percentage of cells responding to ATP with an increase in 
[Ca2+]i to >200 nM for 24 hr exposure to (A) nano-HfO2, (B) nano-SiO2, (C) 
nano-CeO2, (D) micron-HfO2, (E) micron-SiO2, and (F) micron-CeO2. Error 




3.4.3 Examining mass and surface area concentration dose-metrics 
Because defining the most appropriate dose metric of ENPs remains a 
challenging issue in nanotoxicology, we more closely examined the doses 
administered to the cell cultures in the previous experiments. An interpretation of 
size-dependent biological responses to ENPs depends on the choice of dose 
metric used for comparison. Examples of nominal dose metrics that have been 
studied are particle mass, particle number, and surface area doses. Since for a 
given mass of particles, the total surface area increases with decreasing particle 
diameter, we hypothesized that the surface area concentration administered to 
the cells would better be a better predictor of ENP exposure effect than the mass 
concentration dose. Therefore, we examined the results from Ca2+ imaging of 
16HBE14o- cell cultures after 24 hr exposure to nano- and micron-sized particles 
(Figure 3.18) on both mass and surface area bases (Figure 3.19). Mass 
concentrations were converted to surface area concentrations with the following 
relationship: 
. mass concentration 6 Surface area concentration = ------- • -
density d 
(1) 
where surface area concentration is in cm2/ml media, mass concentration is in 
g/ml media, density is in g/cm3, dis the average hydrodynamic particle diameter 
in cm (measured by DLS or diffraction, Tables 1 and 2), and particles are 
assumed to be spherical. Conversions were examined for HfO2 and SiO2 
particles because size measurements were available for both nano- and micron-
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sized particles. A particle size measurement was not determined for the micron-
sized CeO2 particles and therefore an accurate surface area concentration could 
not be determined. 
For comparison between mass and surface area dose metrics, the Ca2+ 
responses to 1 µM ATP (Figure 3.18) were plotted against both dose metrics. 
When Ca2+ responses are plotted versus administered mass concentration, 
nano-sized particles cause greater reductions in Ca2+ response for a given mass 
compared to micron-sized particles (Figure 3.19A,B). However, when plotted on 
a surface area basis, a logarithmic relationship develops (Figure 3.19C,D). Ca2+ 
response decreases as total surface area increases, indicating that surface area 
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Figure 3.19: Comparison of mass and surface area concentration dose 
metrics. Ca2+ responses to 1 µm ATP of 16HBE14o- cell cultures exposed 
for 24 hrs to varying mass concentrations of (A) Hf02 and (B) Si02. The 
same responses are plotted against corresponding surface area 
concentrations for (C) Hf02 and (D) Si02, calculated based on the 
assumption of spherical particles and equation 1. 
3.4.4 Examining particle deposition based on sedimentation and diffusion 
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Instead of exposure dose administered to the cell culture, a target tissue 
paradigm for dosimetry has been proposed to improve the accuracy and 
predictive power of in vitro systems for assessing ENP hazards (Hinderliter et al. , 
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2010). The In vitro Sedimentation, Diffusion, and Dosimetry (ISDD) model 
provides mathematical calculations that circumvent direct experimental measures 
of cellular dose, since these can be difficult and expensive. The ISDD model, 
which was developed in Matlab (MathWorks, Inc.), was obtained from the 
authors and used to examine the in vitro target cell dose of our tested ENPs that 
was transported to cells in culture over the duration of exposure. In order to 
determine the fraction of particles transported from media to the bottom of the 
culture well, the ISDD model uses the principles of diffusional and gravitational 
transport of particles in viscous media. Inputs of temperature, media density and 
viscosity, medium height, hydrodynamic particle size in the test media, and 
particle density allow the model to produce a time-course of particle transport, 
and ultimately the fraction of particles delivered to the cells over time. 
We used the ISDD model to look at the time-course of particle delivery to 
the cell culture in order to determine if there were differences in the delivered 
particle dose between the ENPs we examined (Figure 3.20). The model showed 
that of the ENPs tested, SiO2 (368 nm) takes the shortest amount of time, ~2.5 
hrs, to deliver the full administered dose to the cells when exposed in a culture 
well with surface area of 1.8 cm2 and media height of ~1.4 mm (Figure 3.20A). 
However, in all three cases, the full dose was delivered to the cells after ~6 hrs of 
exposure. Therefore, cells exposed to the ENPs for 24 hrs prior to Ca2+ imaging 
experiments had received the full administered dose. 
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Additionally, particle fraction deposited over time was calculated for 
particles administered to cell cultures in 96-well E-plates in order to examine how 
long it takes particles to reach cells in RTCA cytotoxicity assays. Media height 
used in RTCA experiments is ~10.2 mm, which is much greater than media 
heights used in larger wells for cell culture on coverslips (for Ca2+ imaging 
experiments). Since the height of the media above cells in culture determines 
the distance particles must travel to reach cells, it is a large factor in the 
determination of the fraction of particles delivered. Increases in media height 
reduce the fraction of the administered dose reaching cells. Therefore, it is not 
surprising that for E-plate wells with a higher media height, a longer exposure 
time is needed to deliver the full administered dose (Figure 3.208). This is an 
important consideration when examining cytotoxicity demonstrated by cells 
exposed to ENPs. Since only fractions of administered doses are delivered 
during the course of a cytotoxicity experiment, it becomes more difficult to 
compare dose-response data. The ISDD model could not be used on the 
micron-sized particles because their measured diameters were too large for the 
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Figure 3.20: Transport rates for tested ENPs during in vitro 
experiments. ISDD calculated fraction of ENPs delivered to cells over the 
duration of an in vitro exposure (A) in cell culture dish wells with surface 
area of 1.8 cm2/well and (B) in an E-plate with surface area of 0.196 
cm2/well. Different rates of particle transport result in different time-course 
for delivery to cells. Calculations were made with ISDD model provided by 
Hinderliter et al. (Hinderliter et al., 2010). 
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CHAPTER 4 - DISCUSSION 
Currently, there are no exposure limits that address engineered 
nanoparticles. Nor are there standard measurement techniques for ENPs in the 
workplace (Methner et al., 2010). In an era of expanding nanotechnologies and 
widespread production of engineered nanoparticles, ENP hazards must be 
assessed to protect employers, workers, and researchers that are potentially 
exposed in facilities where ENPs are produced and/or handled. A first step in 
establishing human exposure limits is to determine the toxicity of the ENPs. 
However, toxicology assessments fail to keep up with the fast pace at which new 
ENPs are produced. An in vitro toxicity assay that models inhalation or dermal 
exposure to ENPs will be beneficial in assessing the hazards of new ENPs. In 
vitro models that can be used to shed light on biological mechanisms for ENP 
effects are also needed to understand their toxicity. By examining characterized 
ENPs, this thesis established an RTCA assay to evaluate ENP cytotoxicity both 
in terms of cell death and decreased cellular response. 
A toxicity assay like the one developed in this thesis is key to addressing 
the growing knowledge gap between emerging sophisticated materials and 
quantitative toxicology and risk assessment. It is vital to rapidly screen ENPs for 
potential toxicity and adverse cellular effects before they can be further tested for 
causing specific cellular alterations or examined in vivo. However, there is a 
range of approaches and methods that have been used to investigate the effects 
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of manufactured nanoparticles which lead to different results (Oberdorster et al., 
2005). This inconsistency indicates a need for standardized tests in order to get 
comparable results when screening ENPs for toxicity effects. The EPA has 
recognized this need with their establishment of the Working Party on 
Manufactured Nanomaterials (WPMN). One project of the WPMN is to develop 
in vitro tests to evaluate ENPs with a responsible and coordinated approach 
(EPA, 2011 ). An RTCA cytotoxicity assay like the one we developed can be 
standardized, quick, and high-throughput. Furthermore, we were able to modify 
the assay for two different cell types in order to mimic both airway and skin 
exposure. Therefore, this assay can be standardized to maximize coordination 
between studies, but is also versatile, in order to investigate various ENP 
exposure routes. 
Additionally, the RTCA assay not only looks at end point toxicity, but it 
also tracks cellular responses over an extended period of time. This eliminates 
the need to choose a single exposure time at which to evaluate cytotoxicity. 
Since the health and activity of the cells is continuously monitored, we gain 
information about the rate and quantity of cell death, as well as about toxic 
effects in the absence of cell death. ENP exposure has the potential to cause 
toxic effects without reaching the "ultimate" end point of cell death in a toxicity 
experiment. For example, cell transformations or the loss of ability to respond to 
cellular signals or stress could result from ENP exposure (Nel et al., 2006). In 
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this thesis, RTCA was used to examine exposure to ENPs that did not cause cell 
death, but did reduce cellular response to an innate immune signal, ATP. 
This RTCA result led us to further investigate the loss of ATP signaling 
due to ENP exposure. Although a loss of signaling is not "toxic" in terms of cell 
death, alterations of signaling pathways can contribute to chronic disease and 
therefore can be detrimental. Since an increase in [Ca2+]i is part of a signaling 
pathway downstream from ATP activation, we examined [Ca2+]i changes in 
response to ATP. We exposed airway epithelial cells to sub-cytotoxic ENP 
concentrations and showed that their [Ca2+]i response to a typical signaling 
concentration of ATP was reduced. However, since ENP physical and chemical 
characteristics play a large part in their toxicity effects, it was not surprising that 
the three ENPs tested (with varying sizes) did not cause identical reductions in 
signaling. These differences highlight the importance of thorough ENP physical 
and chemical characterizations that should be carried out when examining the 
potential adverse effects of ENPs. To fully describe the differences between the 
particles and gain further understanding of why they can cause different 
biological effects, we need to accurately characterize the particle surface area, 
crystal structure, agglomeration status in relevant media, composition and 
surface coatings, surface reactivity, method of synthesis and post-synthesis 
modifications, and purity of the sample (Warheit et al., 2009). 
A highly debated issue in nanotoxicology is the potential particle size-
dependence of ENP toxicity. In order to investigate the hypothesis that smaller 
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particles induce greater toxicity due to greater biological interactions, we 
examined the [Ca2+]i response to ATP on airway epithelial cells exposed to 
micron-sized particles, much larger in size than the ENPs tested. Although the 
nano-sized particles did reduce the Ca2+ signal at lower concentrations than the 
micron-sized particles, there was not a direct correlation between sizes. 
Significant reductions in [Ca2+]i response to ATP were caused by exposure to 
micron-sized Hf02 and Ce02. Micron-sized Si02 particles were the only particles 
tested that did not significantly affect Ca2+ signaling at the concentrations tested. 
Therefore, we can conclude that the alterations in [Ca2+]i changes caused by 
particle exposure are not only based on the size of the particles. 
However, one consequence of the small size of nanoparticles is that they 
have a large total surface area, which can potentially lead to increased biological 
interactions and therefore larger cellular effects. We examined this hypothesis 
by relating decreases in [Ca2+]i responses to ATP to ENP surface area exposures 
(calculated based on mass concentration, particle density, and measured 
hydrodynamic size). This showed a toxicity response that was logarithmically 
related to surface concentration, indicating that toxicity may be better predicted 
by the amount of ENP surface area exposed to cells, rather than particle size 
alone. 
Another issue related to the dose metrics used to assess ENP toxicity with 
in vitro assays is the affect of solution dynamics, including particle diffusion and 
sedimentation (Teeguarden et al., 2007). The ENP dose in an in vitro system 
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can be difficult to compare across particle types that have varying densities, 
shapes, surface properties, and sizes. An assessment of the actual cellular dose 
exposed to the cells should be considered when evaluating impacts of nominal 
doses of ENPs. Therefore, we used a computational model to describe the rate 
at which the ENPs are delivered to the target tissue, based on sedimentation and 
diffusion (Hinderliter et al., 2010). We found that media height has a high impact 
on the rate of deposition, indicating that this, as well as other parameters 
affecting diffusion and sedimentation, should be taken into account when 
comparing cellular responses across systems. 
The current work has shown that sub-cytotoxic concentrations of ENPs 
have the potential to cause detrimental effects to human airway epithelial cells by 
reducing the cellular response to ATP. However, ATP signaling can mediate a 
diverse spectrum of effects in many cell types upon receptor binding (Ahmad et 
al., 2006). Future work should investigate the receptors that bind ATP (P2X and 
P2Y) and the specific pathways that may be affected by ENPs. Also, purinergic 
receptors have been shown to be involved in the cellular response to oxidative 
stress (Mason et al., 2004), which is often produced by the presence of ENPs 
(Akhtar et al., 201 0; Park et al., 2008). Therefore, the potential link between 




CHAPTER 5 - CONCLUSIONS AND FUTURE WORK 
A major goal of this work was to examine the cytotoxicity effects of ENPs 
to cultured human airway epithelial cells. A limitation encountered was that the 
examined ENPs were not actually in the nano-size range (< 100 nm in diameter). 
Although the particle sizes of the ENPs used in these studies were reported by 
the suppliers to be nano-sized, particle diameters measured by DLS and laser 
diffraction were much larger. This inconsistency limited our conclusions related 
to ENP toxicity. Although we observed cell death due to SiO2 particles and 
reductions in cell signaling due to HfO2, SiO2, and CeO2 particles, we cannot 
conclude that these affects are due to "nanotoxicity"; but rather, they may result 
from a metal toxicity. In order to complete this evaluation, future experiments 
should examine the potential toxicity of true nanoparticles to better assess size-
dependent effects. 
We can conclude that sub-cytotoxic exposures to engineered particles 
can alter basic innate immune function in lung epithelial cells, including paracrine 
response to ATP signaling. Although these particle exposures did not cause cell 
death, they present detrimental health hazards that simple cell death assays do 
not reveal. In order to further the studies in this work, the effects of micron-sized 
particle exposure should be investigated with the RTCA assay in terms of both 
cell death and reduced ATP signaling. This comparison of micron-size particles 
to nano-sized particles would help to determine if cytotoxicity and the dampening 
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of overall signaling response to ATP is related to the particles' nano-size or their 
metal properties. Furthermore, potential particle interactions with ATP should be 
examined, since ATP-nanoparticle interactions could potentially limit available 
ATP and therefore decrease the response. In order to examine the ATP 
response without opportunity for ATP-particle interaction, the experiments done 
in this work could be modified. For example, if after a 24 hr ENP exposure, the 
particles were washed off the cell culture, and then ATP was administered, 
potential ATP binding to nanoparticles would be avoided. In this way, it could be 
determined if nanoparticles decrease the ATP signaling response by interfering 
with ATP or by affecting the cell directly. 
Other parameters of nanoparticle cytotoxicity should also be examined. 
For example, surface charge can affect the internalization of nanoparticles and 
therefore toxicity. Measuring the zeta potential of the particles is one way to 
assess the charge surrounding a nanoparticle in solution, and the zeta potential 
may affect the particle's ability to permeate the cell membrane (Clogston and 
Patri, 2011 ). For example, particles with a more positive zeta potential can have 
a higher tendency to enter cells or disrupt cell membranes, and therefore show 
greater toxicity. If we measure the zeta potentials of the nanoparticles we are 
examining (Hf02, Ce02, Si02,), a relationship between zeta potential and the 
induced cytotoxicity that we observe could emerge. Furthermore, studies have 
coated nanoparticles with polymers or functional groups to create particles that 
are positive, negative, or neutrally charged, but with the same core (e.g. Ce02), 
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showing a surface charge-dependent localization that may play a role in the 
particle's toxicity (Asati et al., 2010; Bhattacharjee et al., 2010). An approach like 
this could be used to show how the surface charge affects the toxicity of a 
nanoparticle like HfO2. Another parameter to investigate that is related to 
nanoparticle toxicity effects is the presence of free metal ions. For example, 
toxic effects of Cu nanoparticles are increased due to high copper ion 
concentrations that result from the high reactivity of Cu nanoparticles (Griffitt et 
al., 2008). The difference in toxicity may arise from different uptake 
mechanisms. For example, metal nanoparticles may be too big for ion 
transporters or paracellular diffusion pathways, but may likely be endocytosed. 
Metal nanoparticles could also exert toxic effects without uptake into internal 
organs. In future studies with HfO2, the effects of nano-metal and dissolved 
metals should be investigated. To determine if there is a difference in toxicity of 
nano-metal and dissolved metals, we could examine hafnium in the ionic state 
using a hafnium salt (HfCl4), and compare the metal salt toxicity to the 
nanoparticle toxicity. 
With these proposed experiments, in combination with the findings of this 
study, we would be able to better understand the parameters of nanoparticles 
like HfO2 that contribute to or enhance toxicity effects. Exposure of airway 
epithelial cells to HfO2 particles was shown to cause toxicity in terms of reduced 
paracrine response to ATP signaling. By examining true nanoparticles alongside 
the slightly larger particles studied in this work, we would help to elucidate altered 
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toxic effects due to the differing physicochemical features of nanoparticles. A 
second important outcome from the experiments discussed above would be a 
better identification of distinct properties of the particles that are involved in their 
toxic effects; these include a possible surface charge dependency or a 
contribution of free metal ions. With these studies, the extremely limited data on 
Hf02 toxicity that arises from both nano- and metal-based mechanisms would be 
enhanced. Further, as a model nanoparticle, this approach and resulting data 
could provide important information on more commonly used nanoparticles. 
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